Hot Features
Premium
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Période:
Mode Dessin:
| Volume | 71 248 |
|
|||||
| Actualités | - | ||||||
| Maximum Haut | 2,61 | Bas Haut |
|||||
| Minimum Bas | 2,5001 | ||||||
| Nom Action | Symbole Action | Marché | Type |
|---|---|---|---|
| Oramed Pharmaceuticals Inc | ORMP | NASDAQ | Action ordinaire |
| Variation Action | Variation Action% | Cours Dernier | Dernier échange
|
|
|---|---|---|---|---|
| -0,005 | -0,19% | 2,565 | 16:38:31 |
| Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
|---|---|---|---|---|
| 2,53 | 2,5001 | 2,61 | 2,57 |
| Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
|---|---|---|---|---|---|
| 456 | 71 248 | US$ 2,56 | US$ 182 188 | - | 1,67 - 3,70 |
| Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
|---|---|---|---|---|
| 16:38:31 | 106 | US$ 2,565 | USD |
Bilan Comptable
| Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
|---|---|---|---|---|---|---|
| 104,01M | 40,63M | - | 1,63M | 5,53M | 0,14 | 18,82 |
| Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
plus d’informations financières »
Actualités Action Oramed Pharmaceuticals
| Date | Heure | Source | Titre |
|---|---|---|---|
| 26/6/2024 | 15:05 | PR Newswire (US) | Oramed Letter to Shareholders |
| 26/6/2024 | 15:00 | PR Newswire (US) | Oramed Pharmaceuticals Inc. Announces the Buy-Back of its.. |
| 20/6/2024 | 13:32 | Edgar (US Regulatory) | Form ARS - Annual Report to Security Holders |
| 20/6/2024 | 13:30 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 10/6/2024 | 23:28 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/6/2024 | 23:15 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 09/5/2024 | 23:00 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 06/5/2024 | 15:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 19/3/2024 | 14:00 | GlobeNewswire Inc. | Scilex Holding Company Announces Repayment in Full of the.. |
| 06/3/2024 | 23:00 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 20/2/2024 | 14:42 | Edgar (US Regulatory) | Form 8-K - Current report |
| 20/2/2024 | 14:30 | PR Newswire (US) | Oramed Letter to Shareholders |
Forum Action Oramed Pharmaceuticals
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Oramed Pharmaceuticals Inc
| Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
|---|---|---|---|---|---|---|---|
| 1 semaine | 2,19 | 2,775 | 2,14 | 2,50 | 354 758 | 0,375 | 17,12% |
| 1 mois | 2,19 | 2,775 | 2,00 | 2,35 | 210 942 | 0,375 | 17,12% |
| 3 mois | 2,74 | 2,81 | 2,00 | 2,37 | 134 145 | -0,175 | -6,39% |
| 6 mois | 2,15 | 3,67 | 2,00 | 2,66 | 158 658 | 0,415 | 19,30% |
| 1 an | 3,38 | 3,70 | 1,67 | 2,67 | 177 650 | -0,815 | -24,11% |
| 3 ans | 13,85 | 31,54 | 1,67 | 8,24 | 678 236 | -11,29 | -81,48% |
| 5 ans | 3,5754 | 31,54 | 1,67 | 7,99 | 529 896 | -1,01 | -28,26% |
